Compare iShares 0 3 Month Treasury Bond ETF (SGOV) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares 0 3 Month Treasury Bond ETF vs Vir Biotechnology Inc. Common Stock — how do they compare? iShares 0 3 Month Treasury Bond ETF trades at $100.55 (market cap $115.19B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: iShares 0 3 Month Treasury Bond ETF is far larger — about 64× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, iShares 0 3 Month Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares 0 3 Month Treasury Bond ETF for 51 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SGOV | VIR | |
|---|---|---|
Market Cap | $115.19B | $1.80B |
Volume | 18,240,700 | 1,782,836 |
Sector | Fixed Income | Health |
52-Week High | $100.72 | $11.78 |
52-Week Low | $100.28 | $5.12 |
Typical Hold Time | 51 Days | 0 Days |
Enterprise Value | — | $1.36B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SGOV, the iShares 0-3 Month Treasury Bond ETF, trades at $100.52 with no price change. The technical outlook is bearish, driven by moving averages, while oscillators are neutral. Recent corporate actions include scheduled dividend payments through late 2026. Market sentiment is influenced by a significant bond selloff and rising Treasury yields, with institutional activity showing a reduction in holdings by Envestnet Asset Management.
The outlook for SGOV is cautious amid a challenging bond market environment. Investment opportunities lie in its short-duration Treasury exposure during rate volatility, but risks include prolonged high interest rates and inflation pressures. Investors should weigh the ETF's stability against macroeconomic headwinds impacting fixed income.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares 0 3 Month Treasury Bond ETF
SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.
Read more on SGOV →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
